NDC 0026-9711 - Viadur
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0026-9711
- Package NDCs from labels
- 0026-9711-01
- Manufacturer
- Bayer Pharmaceuticals Corporation
- Effective date
- 2006-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Viadur - Bayer Pharmaceuticals Corporation | Bayer Pharmaceuticals Corporation | 2006-05-10 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0026-9711-01 | Viadur | 1 in 1 BOX | KIT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-08-05 | Warnings, Adverse reactions | 1010671 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 573a7298-b02e-230c-e063-6294a90a269c | 2026-07-22 | Warnings, Adverse reactions | 1010671 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 9a1418e2-b208-4e5c-b5f8-21b3a691a578 | 2026-04-13 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Anthea Pharma Private Limited | 240c4744-e58c-4c08-93ad-8d6418c4f8a9 | 2026-02-11 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 415a29c1-101a-4ac2-9ba9-b419a1ce5600 | 2026-02-03 | Warnings, Adverse reactions | 1010671 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 94155012-b1fc-430a-a1f5-30c21f4a3f80 | 2026-02-03 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42d9e4cf-ca73-ec6d-e063-6394a90ae937 | 2025-12-18 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e824ba5b-3289-5ad4-e053-2995a90acc20 | 2025-11-27 | Warnings, Adverse reactions | 1010671 |
| Xylocaine | LIDOCAINE HCL | Henry Schein, Inc. | a6019956-a6e0-4988-a870-6aee06c354c3 | 2025-11-07 | Warnings, Adverse reactions | 1010671 |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | e6c83ad7-2821-432b-8610-0f54cfe610cb | 2025-10-21 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | bb53bb10-bb36-4c9b-b632-71455615f9f3 | 2025-09-29 | Warnings, Adverse reactions | 1010671 |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 953471e2-9efb-adf0-e053-2a95a90afd95 | 2025-07-09 | Warnings, Adverse reactions | 1010671 |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 767374af-89d1-4c19-bd8e-480699b45cf7 | 2025-06-11 | Warnings, Adverse reactions | 1010671 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 25370b0f-0ac6-4a03-abe6-d73d65192180 | 2025-05-31 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Huons Co., Ltd. | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 2025-05-09 | Warnings, Adverse reactions | 1010671 |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 5523fdfe-69fd-49a5-b51f-73e2223d49a9 | 2025-05-01 | Warnings, Adverse reactions | 1010671 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | 4dd52202-8eef-4136-92dd-ada573b7cf74 | 2025-04-22 | Warnings, Adverse reactions | 1010671 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NorthStar RxLLC | 6a7fa6c5-b550-46ac-99a3-5c49339e6dbd | 2025-02-19 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Eugia US LLC | ccc38d8a-43fd-44c0-985e-32af9ed956ab | 2025-02-03 | Warnings, Adverse reactions | 1010671 |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999b1c7b-3495-926a-e053-2a95a90ab206 | 2025-01-08 | Warnings, Adverse reactions | 1010671 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.